These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous. Xing X; Feldman AL Adv Anat Pathol; 2015 Jan; 22(1):29-49. PubMed ID: 25461779 [TBL] [Abstract][Full Text] [Related]
3. Cutaneous anaplastic large-cell lymphoma should be evaluated for systemic involvement regardless of ALK-1 status: case reports and review of literature. Yang S; Khera P; Wahlgren C; Ho J; Jukic D; Geskin L; English JC Am J Clin Dermatol; 2011 Jun; 12(3):203-9. PubMed ID: 21366363 [TBL] [Abstract][Full Text] [Related]
4. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules. Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575 [TBL] [Abstract][Full Text] [Related]
5. ALCL by any other name: the many facets of anaplastic large cell lymphoma. Irshaid L; Xu ML Pathology; 2020 Jan; 52(1):100-110. PubMed ID: 31706671 [TBL] [Abstract][Full Text] [Related]
6. Skin involvement as the first symptom of rapidly progressive ALK-positive systemic anaplastic large cell lymphoma. Yu X; Zhang J; Xu K; Li M; Yao Z Clin Exp Dermatol; 2017 Jul; 42(5):539-542. PubMed ID: 28556361 [TBL] [Abstract][Full Text] [Related]
7. A Case of ALK+ Anaplastic Large-Cell Lymphoma With Aberrant Myeloperoxidase Expression and Initial Cutaneous Presentation. Gru AA; Voorhess PJ Am J Dermatopathol; 2018 Jul; 40(7):519-522. PubMed ID: 29905579 [TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options. Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794 [TBL] [Abstract][Full Text] [Related]
9. Anaplastic large cell lymphoma: an unusual presentation in a 7-year-old girl. Ju E; Adigun C; Dunphy C; Gold S; Morrell DS Pediatr Dermatol; 2012; 29(4):498-503. PubMed ID: 21967522 [TBL] [Abstract][Full Text] [Related]
10. Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma. Lae ME; Ahmed I; Macon WR Am J Clin Pathol; 2002 Nov; 118(5):773-9. PubMed ID: 12428799 [TBL] [Abstract][Full Text] [Related]
11. ALK-Negative Primary Cutaneous Anaplastic Large Cell Lymphoma With Systemic Involvement or Systemic ALCL With Cutaneous Lesion. A Diagnostic Dilemma. Gupta I; Ramteke P; Narwal A; Sharma MC; Bakhshi S; Mallick S Am J Dermatopathol; 2022 May; 44(5):376-379. PubMed ID: 35234192 [TBL] [Abstract][Full Text] [Related]
12. Pediatric case of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma forming a solitary skin tumor on the forearm. Tokuyama M; Kurashige Y; Ota T; Manabe Y; Yamaoka H; Ikoma N; Fukumura A; Miyashita M; Otsubo K; Morimoto T; Mochizuki H; Nakano N; Nakamura N; Ozawa A; Mabuchi T J Dermatol; 2017 Apr; 44(4):465-467. PubMed ID: 27864829 [TBL] [Abstract][Full Text] [Related]
13. How I Diagnose Anaplastic Large Cell Lymphoma. Amador C; Feldman AL Am J Clin Pathol; 2021 Mar; 155(4):479-497. PubMed ID: 33686426 [TBL] [Abstract][Full Text] [Related]
14. ALK-negative systemic intravascular anaplastic large cell lymphoma presenting in the skin. Rieger KE; Polidore T; Warnke R; Kim J J Cutan Pathol; 2011 Feb; 38(2):216-20. PubMed ID: 20236372 [TBL] [Abstract][Full Text] [Related]
15. Cutaneous anaplastic large cell lymphomas: a report of 9 cases from Thailand. Eimpunth S; Sittinamsuwan P; Pattanaprichakul P; Silpa-archa N; Sethabutra P; Chularojanamontri L; Hanamornroongruang S; Mahaisavariya P J Med Assoc Thai; 2012 Mar; 95(3):437-43. PubMed ID: 22550845 [TBL] [Abstract][Full Text] [Related]
16. ALK-negative anaplastic large cell lymphoma with "Hodgkin-like" cytomorphology and nuclear expression of PAX5. Fratoni S; Niscola P; Zhao XF; Larocca LM; Capalbo A; Fabbretti M; Bernardini L; Abruzzese E Pathol Res Pract; 2020 Feb; 216(2):152724. PubMed ID: 31784094 [TBL] [Abstract][Full Text] [Related]
17. Recurrent ALK-negative anaplastic large T-cell lymphoma presenting as necrotizing vasculitis. Nambudiri VE; Aboutalebi A; Granter SR; Saavedra A Am J Dermatopathol; 2013 Jun; 35(4):512-6. PubMed ID: 23291583 [TBL] [Abstract][Full Text] [Related]
18. Advances in the treatment and prognosis of anaplastic lymphoma kinase negative anaplastic large cell lymphoma. Wang X; Wu J; Zhang M Hematology; 2019 Dec; 24(1):440-445. PubMed ID: 31072226 [TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative. Kadin ME; Pinkus JL; Pinkus GS; Duran IH; Fuller CE; Onciu M; Kawaguchi H; Morris SW Am J Surg Pathol; 2008 Sep; 32(9):1421-6. PubMed ID: 18670345 [TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous anaplastic large cell lymphoma. Brown RA; Fernandez-Pol S; Kim J J Cutan Pathol; 2017 Jun; 44(6):570-577. PubMed ID: 28342276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]